drugset / Trial / NCT01442766

Donepezil Trial for Motor Recovery in Acute Stroke

NCT01442766

RandomizedParallel-groupQuadruple-blindTreatment

Summary

AIMS: To establish: 1) whether motor deficits in acute stroke improve more in patients taking donepezil, relative to placebo, for 12 weeks; 2) whether brain functional MRI changes as a result of donepezil after 12 weeks.

Timeline

Start
2011-11
Primary completion
2013-11
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 10 mg

Indications